Despite the inter-tumor heterogeneity present in GBM, GSCs seem to share, as a common denominator, Bcl-xL and Mcl-1 as pivotal factors in mounting the anti-apoptotic response. The gene discussed is BCL2L1; the disease is neoplasm.